Vascular Biology and Metabolism (VAM)

Overview

The VAM area was created to allow a comprehensive, cooperative and multidisciplinary approach in basic, clinical and epidemiology research. The ultimate goal is the innovation and transfer of solutions in a group of diseases that are closely interrelated and that constitute the leading cause of morbidity and mortality in the world: cardio-cerebrovascular disease, diabetes-metabolic syndrome and renal impairment. The VAM area includes preclinical and clinical research staff from our center, and collaborative work with groups of the highest international prestige. VAM area includes 8 groups: Cardiovascular Pathology, Diabetes and Metabolism, Nephrology, Ophthalmology (focused on retinal vascular disease), CIBBIM-Nanomedicine and Kidney Physiopathology, Medical Molecular Imaging, Neurovascular Diseases, and Research on Aging, Frailty and Transitions in Barcelona. All groups use an integrative tridimensional approach to generate knowledge on the mechanisms of diseases to generate new diagnostic and therapeutic tools.

Publications

281

total

1353

impact factor

4.81

average impact factor

Group Leader: Daniel Serón Micas

team

group-zoom

zoom

group-download

download

The Nephrology research group of VHIR is the research group that covers structured care in kidney patients in two main areas: 1) clinical nephrology / dialysis 2) kidney transplantation. In 2020, the group has consolidated the following research lines with competitive grants: onconephrology (Rio Hortega (CM20/00111) and Ministerio de Ciencia e innovación (EIN2020-1123381) and rare nephrology diseases (granted by Marató TV3, two projects: 421/C/2020 and 759/U/2020). Dra. Conxita Jacobs Cachá research has been recognized with the XXXII “Íñigo Álvarez de Toledo” Award for Applied or Clinical Research in Nephrology. The group has been actively involved in COVID-19 research Dr. Soler become board member of the COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group (http://www.nephjc.com/news/covidace2) launched in the early COVID-19, and is also leading the WG5: “Renin-Angiotensin-Aldosterone system in COVID-19″ in the Vall d´Hebron COVID- 19 Task Force.

44

total

192

impact factor

4^.36

average impact factor

SELECTED ARTICLES

Oleas D, Bolufer M, Agraz I, Felip E, Muñoz E, Gabaldón A, Bury R, Espinel E, Serón D, García-Carro C, Soler MJ.
Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.
Clin Kidney J. 2020 Feb 10;14(5):1364-1370.
doi: 10.1093/ckj/sfaa008.
IF: 4.452
Moreso F, Sellarès J, Soler MJ, Serón D.
Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria.
Moreso F, Sellarès J, Soler MJ, Serón D.
Int J Mol Sci. 2020 Mar 24;21(6):2245.
doi: 10.3390/ijms21062245.
IF: 5.923
O Jacobs-Cachá C, Vergara A, García-Carro C, Agraz I, Toapanta-Gaibor N, Ariceta G, Moreso F, Serón D, López-Hellín J, Soler MJ.
Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers.
Clin Kidney J. 2020 Aug 11;14(2):482-491.
doi: 10.1093/ckj/sfaa110
IF: 4.452
JARQUE M, CRESPO E, MELILLI E, GUTIÉRREZ A, MORESO F, GUIRADO L, REVUELTA I, MONTERO N, TORRAS J, RIERA L, MENEGHINI M, TACO O, MANONELLES A, PAUL J, SERON D, FACUNDO C, CRUZADO JM, GIL VERNET S, GRINYÓ JM, BESTARD O. Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial.
Clin Infect Dis. 2020 Dec 3;71(9):2375-2385.
doi: 10.1093/cid/ciz1209.
IF: 9.079. SI: Infectious Disease (3 out of 92)
FAVÀ A, CUCCHIARI D, MONTERO N, TOAPANTA N, CENTELLAS FJ, VILA-SANTANDREU A, COLOMA A, MENEGHINI M, MANONELLES A, SELLARÉS J, TORRES I, GELPI R, LORENZO I, VENTURA-AGUIAR P, COFAN F, TORREGROSA JV, PERELLÓ M, FACUNDO C, SERON D, OPPENHEIMER F, BESTARD O, CRUZADO JM, MORESO F, MELILLI E. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study.
Am J Transplant. 2020 Nov;20(11):3030-3041.
doi: 10.1111/ajt.16246. Epub 2020 Sep 23.
IF: 8.085. SI: Am J Transplantation (2 out of 25); Surgery (6 out of 212)

View all publications